Home / Medicine / Cortexin (polypeptides of the cerebral cortex of cattle)

Cortexin (polypeptides of the cerebral cortex of cattle)

Recorded active ingredients: Polypeptides of the cerebral cortex of cattle

Based on a snapshot of pillintrip.com listings. Country listings do not confirm current availability or registration. Sources and limitations · How matching works.

Countries

Medicines with the same recorded active ingredients

These listings match the full ingredient set recorded for Cortexin (polypeptides of the cerebral cortex of cattle). Strength, dosage form and route may differ or be missing. This does not establish interchangeability; confirm a suitable product with a pharmacist.

Pharmacy sales terms

According to the recipe.

Pharmacotherapeutic group

  • Nootropic agent [Nootropics]

Special precautions for storage

In a place protected from light, at a temperature not exceeding 25 °C.

Keep out of reach of children.

Shelf life of the drug Cortexin® for children3 года.

Do not use after the expiration date indicated on the package.

Nature and contents of container

Lyophilizate for the preparation of a solution for intramuscular administration 1 fl.
active substance:  
cortexin (complex of water-soluble polypeptide fractions) 5 mg
auxiliary substance: glycine (stabilizer) — 6 mg  
Release form

Lyophilizate for the preparation of a solution for intravenous administration, 5 mg. 11 mg in a bottle with a capacity of 3 ml, 5 fl. in a contour cell package made of PVC or PET film and aluminum foil. 2 contour cell packages in a pack of cardboard.

Nosological classification (ICD-10)

  • F06. 6 Organic emotionally labile [asthenic] disorder
  • F80 Specific speech and language development disorders
  • F81 Specific learning skills development disorders
  • G04 Encephalitis, myelitis and encephalomyelitis
  • G40. 9 Unspecified epilepsy
  • G80 Cerebral palsy
  • G93. 4 Encephalopathy, unspecified
  • I67. 9 Cerebrovascular disease, unspecified
  • R41. 3 Other amnesias
  • R41. 8. 0* Intellectual-mnestic disorders
  • R53 Malaise and fatigue
  • R62. 0 Delayed development stages
  • S06 Intracranial injury

Dosage (Posology) and method of administration

In/m. The contents of the bottle before injection are dissolved in 1-2 ml of 0.5% procaine (novocaine) solution, water for injection or 0.9% sodium chloride solution, directing the needle to the wall of the bottle to avoid foaming, and administered once daily: children under 20 kg-at a dose of 0.5 mg/kg, more than 20 kg-at a dose of 10 mg for 10 days.

If necessary, repeat the course after 3-6 months.

ATC - Anatomical and therapeutic chemical classification

N06BX Other psychostimulants and nootropic drugs

Listed in 1 countries